News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Slideshows|March 13, 2020

7 Ways to Break Barriers When Working With LGBTQ-Identified Patients

Author(s)Albina Veltman, MD, Tara La Rose, MSW, PhD, RSW

Albina Veltman, MD, FRCPC and Tara La Rose, MSW, PhD, RSW, provide Suggestions on how to create an LGBTQ-positive space in health care settings.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

Accelerated FDA Action for Psychedelics: Insights From Daniel R. Karlin, MD, MA

FDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use Disorder

A Review of Data on AXS-05 for Alzheimer Disease Agitation in Advance of Next Week's PDUFA Date

Prolactin Monitoring for Antipsychotics and the Impact of Stress

Rational Off-Label Prescribing: A Review With Joseph F. Goldberg, MD, and Henry Nasrallah, MD